Lasonji A Holman, C.R.N.P.
National Institute of Allergy and Infectious Diseases (NIAID)
4
4
2
N/A
0
13
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
François Raffi, PHD
Hopital Hotel Dieu Nantes
Shared therapeutic areas:
Veryl Hodges, DO
Clopton Clinic
Shared therapeutic areas:
Shaukat A. Shah, MD
St. Joseph's Medical Associates, Stockton, CA 95204
Shared therapeutic areas:
Keith S. Reisinger, MD, MPH
Primary Physicians Research, Inc
Shared therapeutic areas:
Gilles Pichancourt
CH Henri Duffaut Avignon
Shared therapeutic areas:
Bruno Marchou, PHD
CHU Purpan (Toulouse)
Shared therapeutic areas:
Giuseppe D'Ignazio, MD
Source Unique Clinic
Shared therapeutic areas:
Lawrence P. Schwartz, MD
HCCA Clinical Research Solutions, New York, NY 10016
Shared therapeutic areas:
Terry L Poling, MD
Heartland Research Associates, LLC, Wichita, KS 67207
Shared therapeutic areas:
Jean Luc Schmit
Hôpital Nord Amiens
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
All 4 trials loaded